Development and production aspects of a recombinant yeast-derived hepatitis B vaccine

This publication has 12 references indexed in Scilit:

• Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness
  Vaccine, 1988
• Lack of Induction of IgE and IgG Antibodies to Yeast in Humans Immunized with Recombinant Hepatitis B Vaccines
  International Archives of Allergy and Immunology, 1988
• Production and immunological analysis of recombinant hepatitis B vaccine
  Journal of Infection, 1986
• Acceptance of Hepatitis B Vaccine by Hospital Personnel
  Infection Control, 1985
• A Multi-Hospital Hepatitis B Vaccine Program: Prevalence of Antibody and Acceptance of Vaccination Among High-Risk Hospital Employees
  Infection Control, 1985
• Who should be immunised against hepatitis B?
  BMJ, 1984
• A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final report
  Hepatology, 1981
• Synthesis of hepatitis B surface and core antigens in E. coli
  Nature, 1981
• RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: I, MEDICAL STAFF
  The Lancet, 1981
• Viral hepatitis, type B (MS-2 strain). Studies on active immunization
  Published by American Medical Association (AMA) ,1971